DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Comparison of Decolonization of Methicillin-resistant Staphylococcus Aureus (MRSA) Using Theraworx

Information source: St. John's Health System, Missouri
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Methicillin-resistant Staphylococcus Aureus

Intervention: Theraworx (Other); mupirocin antibiotic ointment (Drug)

Phase: N/A

Status: Withdrawn

Sponsored by: St. John's Health System, Missouri

Official(s) and/or principal investigator(s):
Roger E Huckfeldt, MD, Principal Investigator, Affiliation: St. Johns' Health System-Medical Research Institute


The purpose of this study is to examine treatment method of Methicillin-resistant Staphylococcus aureus (MRSA) decolonization in patients.

Clinical Details

Official title: Comparison of Decolonization of MRSA Using Theraworx

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Primary outcome: Evidence of decolonization confirmed by intranasal culture

Secondary outcome: Economic-Cost comparison of treatment Evidence of decolonization

Detailed description: Decolonization therapy is indicated for management of patients with MRSA. Theraworx is reported to be an effective antimicrobial against multiple organisms. In this study, patients with positive MRSA colonization culture will be treated with Theraworx to evaluate decolonization duration capability.


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- Positive MRSA culture

Exclusion Criteria:

- Patients currently on or start antibiotic therapy directed for MRSA.(Prophylaxis

antibiotic for surgical procedure not considered therapy.)

- Patients with MRSA infected wounds

- Patients under the age of 18 years

- A woman currently pregnant or nursing a child

- Patients participating in another study within 30 days of randomization

Locations and Contacts

St John's Hospital-Medical Research Institute, Springfield, Missouri 65804, United States
Additional Information

Starting date: March 2008
Last updated: January 11, 2010

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017